US 12,350,355 B2
Oral care compositions comprising hops beta acids and fluoride ions
Arif Ali Baig, Mason, OH (US); Tammy Baker, Cincinnati, OH (US); Aaron Reed Biesbrock, Maineville, OH (US); and Samuel James St. John, Cincinnati, OH (US)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on May 24, 2023, as Appl. No. 18/322,979.
Application 18/322,979 is a continuation of application No. 17/037,766, filed on Sep. 30, 2020, granted, now 11,696,881.
Claims priority of provisional application 62/994,893, filed on Mar. 26, 2020.
Claims priority of provisional application 62/985,451, filed on Mar. 5, 2020.
Claims priority of provisional application 62/972,111, filed on Feb. 10, 2020.
Claims priority of provisional application 62/972,109, filed on Feb. 10, 2020.
Claims priority of provisional application 62/943,940, filed on Dec. 5, 2019.
Claims priority of provisional application 62/907,733, filed on Sep. 30, 2019.
Claims priority of provisional application 62/907,736, filed on Sep. 30, 2019.
Claims priority of provisional application 62/907,735, filed on Sep. 30, 2019.
Prior Publication US 2023/0310287 A1, Oct. 5, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/27 (2006.01); A61K 8/20 (2006.01); A61K 8/21 (2006.01); A61K 8/24 (2006.01); A61K 8/35 (2006.01); A61K 8/362 (2006.01); A61K 8/365 (2006.01); A61K 8/44 (2006.01); A61K 8/73 (2006.01); A61K 8/81 (2006.01); A61K 8/97 (2017.01); A61K 8/9789 (2017.01); A61Q 11/00 (2006.01)
CPC A61K 8/27 (2013.01) [A61K 8/20 (2013.01); A61K 8/21 (2013.01); A61K 8/24 (2013.01); A61K 8/35 (2013.01); A61K 8/362 (2013.01); A61K 8/365 (2013.01); A61K 8/44 (2013.01); A61K 8/731 (2013.01); A61K 8/8147 (2013.01); A61K 8/97 (2013.01); A61K 8/9789 (2017.08); A61Q 11/00 (2013.01); A61K 2800/28 (2013.01); A61K 2800/30 (2013.01); A61K 2800/48 (2013.01); A61K 2800/74 (2013.01); A61K 2800/92 (2013.01)] 24 Claims
 
1. An oral care composition comprising:
(a) hops extract comprising hops beta acid and hops oils, wherein the hops extract comprises from greater than 0% to less than 2.5%, by weight of the hops extract, of the hops oils, wherein the oral care composition comprises from about 0.01% to about 10%, by weight of the composition, of the hops beta acid, and wherein the hops beta acid comprises only non-hydrogenated hops beta acids; and
(b) from about 0.01% to about 10%, by weight of the composition, of fluoride,
wherein the oral care composition has a pH of greater than 7.